Children's Cancer Therapy Development Institute
Dr Narendra Bharathy completed his MSc in Biotechnology at the University of Madras, India, then earned his PhD in Physiology at the National University of Singapore (NUS) under Dr Reshma Taneja. His PhD thesis, 'investigating the role of G9a in skeletal muscle differentiation', addressed epigenetic factors in muscle stem cells and muscle progenitor cells. His findings were published in the Proceedings of the National Academy of Sciences. He is currently a postdoctoral fellow at the Children’s Cancer Therapy Development Institute, USA, working with Dr Charles Keller, a sarcoma expert. His research work involves investigating the mechanisms of a novel epigenetic therapy for children with muscle cancer (rhabdomyosarcoma). His preclinical investigation of a kinase inhibitor in rhabdomyosarcoma was recently published in Oncotarget. His previous postdoctoral work with Dr Taneja also addressed rhabdomyosarcoma and was published in the Journal of Pathology in 2016. His research is devoted to the development of novel molecular therapies for advanced childhood muscle tumors associated with high morbidity or mortality. Narendra has published several research articles in reputed international journals along with reviews and book chapters. He is also serving as a reviewer for reputed international journals, and has attended and presented at international conferences and symposia.